Literature DB >> 17601969

Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement.

J E Larsen1, S J Pavey, R Bowman, I A Yang, B E Clarke, M L Colosimo, N K Hayward, K M Fong.   

Abstract

Tumour, node, metastasis staging is essential for lung cancer management. However, similarly staged cancers may have markedly different prognoses, indicating that stage cannot completely explain tumour behaviour. While ipsilateral hilar node involvement is designated N1, the current authors hypothesised that primary tumours involving nodes by direct extension are biologically distinct from those involving nodes through lymphatic metastasis. Microarrays were used to investigate the gene expression profiles of 59 primary lung squamous cell carcinomas, comparing N0 tumours (n = 35), N1 tumours by direct extension (N1d; n = 8), and N1/N2 tumours by lymphatic metastasis (N1/N2m; n = 16). Hierarchical clustering using 125 genes differentially expressed between N0 and N1/N2m tumours found N1d tumours clustered with N0 tumours. Class prediction modelling found the expression profiles of all eight N1d tumours were more similar to N0 than to N1/N2m tumours. The present study demonstrates for the first time that N1 tumours directly invading hilar nodes are genomically different to those that metastasise via lymphatics. Independent reports suggest that tumours with direct, rather than metastatic node involvement have better outcomes. Consequently, the data suggest that there is a need to re-evaluate the N1 staging definition in lung cancer. This is relevant for prognosis prediction and also for clinical management, particularly in selecting those patients most likely to benefit from adjuvant chemotherapy.

Entities:  

Mesh:

Year:  2007        PMID: 17601969     DOI: 10.1183/09031936.00161306

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

Review 1.  Genomics of lung cancer.

Authors:  Alain C Borczuk; Rebecca L Toonkel; Charles A Powell
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

2.  A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.

Authors:  Elena Martínez-Terroba; Carmen Behrens; Fernando J de Miguel; Jackeline Agorreta; Eduard Monsó; Laura Millares; Cristina Sainz; Miguel Mesa-Guzman; José Luis Pérez-Gracia; María Dolores Lozano; Javier J Zulueta; Ruben Pio; Ignacio I Wistuba; Luis M Montuenga; María J Pajares
Journal:  J Pathol       Date:  2018-06-20       Impact factor: 7.996

3.  Lung cancer with gastrointestinal metastasis - review of theories of metastasis with three rare case descriptions.

Authors:  Rohtesh S Mehta; Andrew D Liman; Vida A Passero; Agnes K Liman
Journal:  Cancer Microenviron       Date:  2013-08-21

Review 4.  Genetic susceptibility to lung cancer and co-morbidities.

Authors:  Ian A Yang; John W Holloway; Kwun M Fong
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

5.  OSluca: An Interactive Web Server to Evaluate Prognostic Biomarkers for Lung Cancer.

Authors:  Zhongyi Yan; Qiang Wang; Zhendong Lu; Xiaoxiao Sun; Pengfei Song; Yifang Dang; Longxiang Xie; Lu Zhang; Yongqiang Li; Wan Zhu; Tiantian Xie; Jing Ma; Yijie Zhang; Xiangqian Guo
Journal:  Front Genet       Date:  2020-05-26       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.